These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Differential actions of typical and atypical antipsychotic drugs on dopamine release in the core and shell of the nucleus accumbens. Marcus MM; Nomikos GG; Svensson TH Eur Neuropsychopharmacol; 1996 Mar; 6(1):29-38. PubMed ID: 8866935 [TBL] [Abstract][Full Text] [Related]
23. Phencyclidine- and dizocilpine-induced hyperlocomotion are differentially mediated. Ogren SO; Goldstein M Neuropsychopharmacology; 1994 Nov; 11(3):167-77. PubMed ID: 7865098 [TBL] [Abstract][Full Text] [Related]
24. The acute and chronic administration of the 5-HT(2B/2C) receptor antagonist SB-200646A significantly alters the activity of spontaneously active midbrain dopamine neurons in the rat: An in vivo extracellular single cell study. Blackburn TP; Suzuki K; Ashby CR Synapse; 2006 Jun; 59(8):502-12. PubMed ID: 16565966 [TBL] [Abstract][Full Text] [Related]
26. Combined serotonin (5-HT)1A agonism, 5-HT(2A) and dopamine D₂ receptor antagonism reproduces atypical antipsychotic drug effects on phencyclidine-impaired novel object recognition in rats. Oyamada Y; Horiguchi M; Rajagopal L; Miyauchi M; Meltzer HY Behav Brain Res; 2015 May; 285():165-75. PubMed ID: 25448429 [TBL] [Abstract][Full Text] [Related]
27. SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system. Di Matteo V; Di Giovanni G; Di Mascio M; Esposito E Neuropharmacology; 1999 Aug; 38(8):1195-205. PubMed ID: 10462132 [TBL] [Abstract][Full Text] [Related]
28. Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study. Di Giovanni G; Di Matteo V; Di Mascio M; Esposito E Synapse; 2000 Jan; 35(1):53-61. PubMed ID: 10579808 [TBL] [Abstract][Full Text] [Related]
29. Inhibitory action of clozapine on rat ventral tegmental area dopamine neurons following increased levels of endogenous kynurenic acid. Schwieler L; Erhardt S Neuropsychopharmacology; 2003 Oct; 28(10):1770-7. PubMed ID: 12865892 [TBL] [Abstract][Full Text] [Related]
30. Expression of 5-HT2A receptors in prefrontal cortex pyramidal neurons projecting to nucleus accumbens. Potential relevance for atypical antipsychotic action. Mocci G; Jiménez-Sánchez L; Adell A; Cortés R; Artigas F Neuropharmacology; 2014 Apr; 79():49-58. PubMed ID: 24211653 [TBL] [Abstract][Full Text] [Related]
31. Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex. Gessa GL; Devoto P; Diana M; Flore G; Melis M; Pistis M Neuropsychopharmacology; 2000 Jun; 22(6):642-9. PubMed ID: 10788763 [TBL] [Abstract][Full Text] [Related]
32. Effect of the acute and chronic administration of the selective 5-HT6 receptor antagonist SB-271046 on the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study. Minabe Y; Shirayama Y; Hashimoto K; Routledge C; Hagan JJ; Ashby CR Synapse; 2004 Apr; 52(1):20-8. PubMed ID: 14755629 [TBL] [Abstract][Full Text] [Related]
33. Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis. Linderholm KR; Andersson A; Olsson S; Olsson E; Snodgrass R; Engberg G; Erhardt S Neuropharmacology; 2007 Dec; 53(8):918-24. PubMed ID: 17959203 [TBL] [Abstract][Full Text] [Related]
34. Differential control of dopamine ascending pathways by serotonin2B receptor antagonists: New opportunities for the treatment of schizophrenia. Devroye C; Cathala A; Haddjeri N; Rovera R; Vallée M; Drago F; Piazza PV; Spampinato U Neuropharmacology; 2016 Oct; 109():59-68. PubMed ID: 27260325 [TBL] [Abstract][Full Text] [Related]